![Inhaled Corticosteroid Inhaler Strengths Beclomethasone Qvar 100-200 >200400 >400 Budesonide Pulmicort 200-400 >400-800 >800 Ciclesonide Alvesco 80-160 >160-320 >320 Fluticasone ... | GrepMed Inhaled Corticosteroid Inhaler Strengths Beclomethasone Qvar 100-200 >200400 >400 Budesonide Pulmicort 200-400 >400-800 >800 Ciclesonide Alvesco 80-160 >160-320 >320 Fluticasone ... | GrepMed](https://img.grepmed.com/uploads/5912/pharmacology-inhaled-doses-inhaler-strengths-original.jpeg)
Inhaled Corticosteroid Inhaler Strengths Beclomethasone Qvar 100-200 >200400 >400 Budesonide Pulmicort 200-400 >400-800 >800 Ciclesonide Alvesco 80-160 >160-320 >320 Fluticasone ... | GrepMed
![Inhaled corticosteroids: effects on the airway vasculature in bronchial asthma | European Respiratory Society Inhaled corticosteroids: effects on the airway vasculature in bronchial asthma | European Respiratory Society](https://erj.ersjournals.com/content/erj/27/1/172/F3.large.jpg)
Inhaled corticosteroids: effects on the airway vasculature in bronchial asthma | European Respiratory Society
![Asthma progression and mortality: the role of inhaled corticosteroids | European Respiratory Society Asthma progression and mortality: the role of inhaled corticosteroids | European Respiratory Society](https://erj.ersjournals.com/content/erj/54/1/1900491/F3.large.jpg)
Asthma progression and mortality: the role of inhaled corticosteroids | European Respiratory Society
![Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 study - The Lancet Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 study - The Lancet](https://www.thelancet.com/cms/attachment/44aecac4-ac94-4664-b187-bd135b351f45/gr1.jpg)
Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 study - The Lancet
![Inhaled corticosteroids in COPD and onset of type 2 diabetes and osteoporosis: matched cohort study | npj Primary Care Respiratory Medicine Inhaled corticosteroids in COPD and onset of type 2 diabetes and osteoporosis: matched cohort study | npj Primary Care Respiratory Medicine](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41533-019-0150-x/MediaObjects/41533_2019_150_Fig3_HTML.png)
Inhaled corticosteroids in COPD and onset of type 2 diabetes and osteoporosis: matched cohort study | npj Primary Care Respiratory Medicine
![Full article: An Analysis of Demographics and Inhaled Corticosteroid Use on COVID-19 Outcomes Among Hospitalized Adult Asthmatics: An Early Experience at a NY Hospital System Full article: An Analysis of Demographics and Inhaled Corticosteroid Use on COVID-19 Outcomes Among Hospitalized Adult Asthmatics: An Early Experience at a NY Hospital System](https://www.tandfonline.com/action/showGraphicalAbstractImage?doi=10.2147%2FJAA.S337518&id=djaa_a_12166973_uf0001_c.jpg)
Full article: An Analysis of Demographics and Inhaled Corticosteroid Use on COVID-19 Outcomes Among Hospitalized Adult Asthmatics: An Early Experience at a NY Hospital System
![Cumulative dispensing of high oral corticosteroid doses for treating asthma in Australia - Hew - 2020 - Medical Journal of Australia - Wiley Online Library Cumulative dispensing of high oral corticosteroid doses for treating asthma in Australia - Hew - 2020 - Medical Journal of Australia - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/0dd6a39b-3e48-4804-93e6-0fdb7cd5b8e3/mja250758-fig-0001-m.jpg)